P. Ouédraogo

发表

Coexistence between (TOHO-type and BES-type) extended-spectrum -lactamase genes of identified enterobacteria at Saint Camille Hospital, Ouagadougou, West Africa

J. Simpore, S. Jacques, T. Zohoncon, 2019 .

Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso.

J. Simpore, P. Ouédraogo, J. Nikiéma, 2007, Pakistan journal of biological sciences : PJBS.

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

A. Ouattara, C. Nadembèga, B. Diarra, 2018, Virology Journal.

World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination

A. Ouattara, L. Traoré, T. R. Compaore, 2017 .

Renal Impairment In Sickle Cell Children In Ouagadougou: Socio-Demographic, Clinical And Associated Factors

G. Coulibaly, S. Kaboret, F. Kouéta, 2019 .

First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso

D. Obiri-Yeboah, S. T. Soubeiga, F. Djigma, 2022, BMC Infectious Diseases.

How (In-)Exact are the Graduated Cups of Medication Syrups in Africa? An Overlooked Aspect of Substandard Drugs for Children.

R. Schumacher, P. Ouédraogo, C. Distefano, 2020, Journal of tropical pediatrics.

First detection of the hemizygote frameshift variant of the DMD gene in a 13-year-old patient affected by dystrophinopathy (Duchenne DMD and Becker BMD) at Saint Camille Hospital of Ouagadougou, Burkina Faso: Case report

A. Ouattara, T. Zohoncon, P. Ouédraogo, 2020 .

Mother-to-Children Plasmodium falciparum Asymptomatic Malaria Transmission at Saint Camille Medical Centre in Ouagadougou, Burkina Faso

V. Colizzi, C. Bisseye, T. R. Compaore, 2014, Malaria research and treatment.

Hepatitis B and C Immunological and Molecular Parameter Analysis in HIV-Positive Patients Undergoing Antiretroviral Therapy at Saint Camille Hospital in Ouagadougou (HOSCO), Burkina Faso

M. Sanou, C. Nadembèga, L. Traoré, 2022, Advances in Infectious Diseases.

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Cote dIvoire

M. Diomande, F. Luquero, B. Nikolay, 2022, medRxiv.

Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns

C. Montesano, M. Amicosante, V. Colizzi, 2018, Journal of public health in Africa.

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

A. Ouattara, C. Nadembèga, L. Traoré, 2018, Virology Journal.

Molecular Epidemiology of Human Herpes Virus Type 8 Among Patients with Compromised Immune System in Ouagadougou, Burkina Faso

T. Sagna, D. Obiri-Yeboah, S. T. Soubeiga, 2022, HIV/AIDS.

HIV_A_353166 311..317

T. Sagna, D. Obiri-Yeboah, S. T. Soubeiga, 2022 .

Impact of a quality improvement intervention on neonatal mortality in a regional hospital in Burkina Faso

F. Cavallin, P. Ouédraogo, J. Bua, 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Bubble CPAP respiratory support devices for infants in low‐resource settings

D. Trevisanuto, R. Dellaca’, V. Ramaswamy, 2022, Pediatric pulmonology.

Incidence of Sickle Cell Disease and Other Hemoglobinopathies in Burkina Faso: Results of a Five-Year Systematic Neonatal Screening (2015-2019) in Four Urban Hospitals

K. Nebie, E. Kafando, H. Zamané, 2022, Open Journal of Blood Diseases.

Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa

P. Rodari, S. Calza, A. Noris, 2014, BMC Infectious Diseases.

Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso

V. Colizzi, L. Traoré, T. Sagna, 2022, Journal of public health in Africa.

[DRESS syndrome secondary to pyrazinamide: An uncommon complication of tuberculosis treatment].

P. Ouédraogo, F. Mbaye, U. D. Kombila, 2018, Revue des maladies respiratoires.

Improved neonatal survival through economically sustainable reorganization of a neonatal care unit in a developing country: 7-year experience in the Centre Medical Saint Camille (CMSC) of Ouagadougou, Burkina Faso

R. Schumacher, P. Ouédraogo, V. Pietra, 2012, Journal of medicine and the person.

Molecular epidemiology of human papillomavirus in pregnant women in Burkina Faso

C. Ouedraogo, D. Obiri-Yeboah, T. Zohoncon, 2022, Biomolecular concepts.

Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso.

Y. Traoré, C. Ouedraogo, D. Obiri-Yeboah, 2016, Pakistan journal of biological sciences : PJBS.

Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso.

V. Deneys, K. Nebie, E. Kafando, 2023, Transfusion Medicine.

Transition of adolescents living with HIV from pediatric to adult care, a retrospective 12-year Single Center Study from the Sahel Region in West-Africa

R. Schumacher, P. Ouédraogo, V. Pietra, 2023, AIDS care.

Impact of COVID-19 on Outpatient Malnutrition Centers in Urban and Rural Burkina Faso

R. Schumacher, P. Ouédraogo, V. Pietra, 2023, American Journal of Tropical Medicine and Hygiene.

Possible Impact of COVID-19 on Children in Africa, Reflections from Italy and Burkina Faso

R. Schumacher, P. Ouédraogo, 2020, Journal of tropical pediatrics.